Gregory J. Tsongalis, BS, MS, PhD
Professor of Pathology & Laboratory Medicine
Director, Clinical Genomics and Advanced Technology (CGAT)
Pathology & Laboratory Medicine
Univ. of Massachusetts, Amherst, BS, 1984
Quinnipiac College, MHS, 1986
Univ. of Medicine and Dentistry of New Jersey, PhD 1990
Uniiv. of North Carolina, Chapel Hill, post-doctoral 1990-1994
Norris Cotton Cancer Center
Program in Experimental and Molecular Medicine
Department of Pathology and Laboratory Medicine
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon NH 03756
Development of advanced diagnostic technologies and disease biomarker discovery.
01/2014-12/30/15; Molecular profiling of tumor and ctDNA, riends of NCCC Scholar $50,000
03/01/13-01/31/2018; 1P20GM104416, Investigator / 2% COBRE Center for Molecular Epidemiology, Federal Direct Costs: $1,793,732
BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease.
Third generation sequencing in the clinical laboratory: Exploring the advantages and challenges of nanopore sequencing.
How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market.
Screening for Human Papillomavirus in a Low- and Middle-Income Country.
Pancreatic cyst fluid harboring a KRAS mutation.
Design of peptide nucleic acid probes on plasmonic gold nanorods for detection of circulating tumor DNA point mutations.
Significant Expansion of Real-Time PCR Multiplexing with Traditional Chemistries using Amplitude Modulation.
Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing.
Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases.
Implementation of Multicolor Melt Curve Analysis for High-Risk Human Papilloma Virus Detection in Low- and Middle-Income Countries: A Pilot Study for Expanded Cervical Cancer Screening in Honduras.